Interleukin-10 inhibits the in vitro proliferation of human activated leukemic CD5+ B-Cells

Leukemia and Lymphoma

Volumn 31, Issue 1-2, 1998, Pages 121-130

  Tangye, Stuart G ^a,b   Weston, Kathryn M ^a   Raison, Robert L ^a  

^a UNIVERSITY OF TECHNOLOGY SYDNEY   (Australia)

^b MERCK RESEARCH LABORATORIES   (United States)

Author keywords

B CLL; Human CD5+ B cells; Interleukin 10

Indexed keywords

ANTIBODY; ANTIMITOTIC AGENT; CD5 ANTIGEN; CYTOKINE; GAMMA INTERFERON; IMMUNOGLOBULIN M; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 2; INTERLEUKIN 4; MEMBRANE ANTIGEN; PHORBOL ESTER; PROTEIN BCL 2; TUMOR NECROSIS FACTOR ALPHA;

APOPTOSIS; ARTICLE; B CELL LEUKEMIA; B LYMPHOCYTE ACTIVATION; CANCER CHEMOTHERAPY; CELL MATURATION; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; DOSE RESPONSE; DOWN REGULATION; HUMAN; HUMAN CELL; IMMUNOGLOBULIN PRODUCTION; LEUKEMIA CELL; PRIORITY JOURNAL; RNA SYNTHESIS;

EID: 0031677776     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.3109/10428199809057592     Document Type: Article

References (36)

1. Moore, K. W., O'Garra, A., de Waal Malefyt, R., Vieira, P. and Mosmann, T. R. (1993). Interleukin-10. Ann. Rev. Immunol., 11, 165.
2. de Waal Malefyt, R., Haanen, J., Spits, H., Roncarolo, M-G., te Velde, A., Figdor, C. G., Johnson, K., Kastelein, R., Yssel, H. and de Vries, J. E. (1991). Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T-cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression. J. Exp. Mal., 174,915.
3. Rousset, F., Garcia, E., Defrance, T., Perrone, C., Vezzio, N., Hsu, D-H., Kastelein, R., Moore, K. W. and Banchereau, J. (1992). Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes. Proc. Natl. Acad. Sci. USA, 89, 1890.
4. Fluckiger, A. C., Garrone, P., Durand, I., Galizzi, J-P. and Banchereau, J. (1993). Interleukin 10 upregulates functional high affinity IL-2 receptors on normal and leukemic B lymphocytes. J. Exp. Med., 178, 1473.
5. Armitage, R. J., Macduff, B. M., Spriggs, M. K. and Fanslow, W. C. (1993). Human B-cell proliferation and Ig secretion induced by recombinant CD40 ligand are modulated by soluble cytokines. J. Immunol., 150, 3671.
6. Defrance, T., Vanbervliet, B., Briere, F., Durand, I., Rousset, F. and Banchereau, J. (1992). Interleukin 10 and transforming growth factor β cooperate to induce anti-CD40-activated naive human B-cells to secrete immunoglobulin. A. J. Exp. Med., 175, 671.
7. 3.J. Exp. Med., 179, 757.
8. Arpin, C., Dechanet, J., van Kooten, C., Merville, P., Grouard, G., Briere, F., Banchereau, J. and Liu, Y-J. (1995). Generation of memory B-cells and plasma cells in vitro. Science, 268, 720.
9. Levy, Y. and Brouet, J. C. (1994). Interleukin-10 prevents spontaneous death of germinal centre B-cells by induction of the bcl-2 protein. J. Clin. Invest., 93, 424.
10. Dighiero, G., Travade, P., Chevret, S., Fenaux, P., Chastang, C., Binet, J-L. and the French Cooperative Group on CLL. (1991). B-cell chronic lymphocytic leukemia: Present status and future directions. Blood, 78, 1901.
11. Freedman, A. S. and Nadler, L. M. (1992). Immunologic markers in B-cell chronic lymphocytic leukemia. In: Chronic lymphocytic leukemia. Scientific advances and clinical developments. B. D. Cheson (ed.). (Marcel Dekker Inc., New York) p. 1.
12. + (B1) B-cells in health and disease. Fund. Clin. Immunol., 2, 9.
13. Fluckiger, A-C., Durand. I. and Banchereau, J. (1994). Interleukin 10 induces apoptotic cell death of B-chronic lymphocytic leukemia cells. J. Exp. Med., 179, 91.
14. Itoh, K. and Hirohata, S. (1995). The role of IL-10 in human B-cell activation, proliferation and differentiation. J. Immunol., 154, 4341.
15. + leukemic B-cells via a T-cell independent mechanism, Immunol. Cell Biol., 73, 44.
16. + B-cells. Immunol. Cell Biol., In press.
17. + B-cells and preserve expression of Bcl-2. Immunol. Cell Biol., 75, 127.
18. Ho, A. S-Y. and Moore, K. W. (1994). Interleukin-10 and its receptor. Ther. Immunol., 1, 173.
19. Jurlander. J., Lai, C.-F., Tan, J., Chou, C-C., Geisler, C. H., Schriber, J., Blumenson, L. E., Narula, S. K., Baumann, H. and Caligiuri, M. A. (1997). Characterization of interleukin-10 receptor expression on B-cell chronic lymphocytic leukemia cells. Blood, 89, 4146.
20. Sarfati, M. (1993). Interleukin-4 and the two isoforms of CD23 antigen: their possible contribution to the physiopathology of chronic lymphocytic leukemia. Nouv. Rev. Fr. Hematol., 35, 109.
21. van Koolen, C., Rensink, I., Aarden, L. and van Oers, R. (1993). Cytokines and intracellular signals involved in the regulation of B-CLL proliferation. Leuk. Lymphoma., 12, 27.
22. Hoffbrand, A. V., Panayiotidis, P., Reittie, J. and Ganeshaguru, K. (1993). Autocrine and paracrine growth loops in chronic lymphocytic leukemia. Semin. Hematol., 30, 306.
23. Carlsson, M., Sundstrom, C., Bengtsson, M., Totterman, T. H., Rosen, A. and Nilsson, K. (1989). Interleukin-4 strongly augments or inhibits DNA synthesis and differentiation of B-type chronic lymphocytic leukemia cells depending on the co-stimulatory activation and progression signals. Eur. J. Immunol., 19, 913.
24. van Kooten, C., Rensink, I., Aarden, L. and van Oers, R. (1993). Effect of IL-4 and IL-6 on the proliferation and differentiation of B chronic lymphocytic leukemia cells. Leukemia, 7, 618.
25. Fluckiger, A. C., Rossi, J. F., Bussel, A., Bryon, P., Banchereau, J. and Defrance, T. (1992). Responsiveness of chronic lymphocytic leukemia B-cells activated via surface Igs or CD40 to B-cell tropic factors. Blood, 80, 3173.
26. Fluckiger, A-C., Briere, F., Zurawski, G., Bridon, J-M. and Banchereau, J. (1994). IL-13 has only a subset of IL-4-like activities on B chronic lymphocytic leukemia cells. Immunology, 83, 397.
27. Dancescu, M., Rubio-Trujillo, M., Biron, G., Bron, D., Delespesse, G. and Sarfati, M. (1992). Interleukin-4 protects chronic lymphocytic leukemia cells from death by apoptotis and upregulates bcl-2 expression. J. Exp. Med., 176, 1319.
28. Panayiotidis, P., Ganeshaguru, K., Jabbar, S. A. B. and Hoffbrand, A. V. (1993). Interleukin-4 inhibits apoptotic cell death and loss of the bcl-2 protein in B-chronic lymphocytic leukemia cells in vitro. Br. J. Haem., 85, 439.
29. Aderka, D., Maor, Y., Novick, D., Engelmann, H., Kahn, Y., Levo, Y., Wallach, D. and Revel, M. (1993). Interleukin-6 inhibits the proliferation of B-chronic lymphocytic leukemia cells that is induced by tumor necrosis factor-α or -β. Blood, 81, 2076.
30. Luo, H., Rubio, M., Biron, G., Delespesse, G. and Sarfati, M. (1991). Antiproliferative effect of interleukin-4 in B chronic lymphocytic leukemia. J. Immunother., 10, 418.
31. Burdin, N., Peronne, C., Banchereau, J. and Rousset F. (1993). Epstein-Barr virus transformation induces B lymphocytes to produce human interleukin 10. J. Exp. Med., 177, 295.
32. Nilsson, K. (1992). The control of growth and differentiation in chronic lymphocytic leukemia (B-CLL) cells. In: Chronic Lymphocytic Leukemia. Scientific Advances and Clinical Developments, B. D. Cheson (ed). (Marcel Dekker Inc., New York) pp. 33.
33. + B-cell apoptosis: Co-incidence of cell death and DNA fragmentation with reduced bcl-2 expression. Br. J. Haem., 92, 950.
34. Marcelletti, J. F. (1996). IL-10 inhibits lipopolysaccharide-induced murine B-cell proliferation and cross-linking of surface antigen receptors or ligation of CD40 restores the response. J. Immunol., 157, 3323.
35. Finke, J., Temes, P., Lange, W., Mertelsmann, R. and Dolken, G. (1993). Expression of interleukin 10 in B lymphocytes of different origin. Leukemia, 7, 1852.
36. Sjoberg, J., Aguilar-Santelises, M., Sjogren, A. M., Pisa, E. K., Ljungdahl, A., Bjorkholm, M., Jondal, M., Mellstedt, H. and Pisa P. (1996). Interleukin-10 mRNA expression in B-cell chronic B lymphocytic leukemia inversely correlates with progression of disease. Br. J. Haem., 92, 393.